Short answer · Medically reviewed summary · Last updated: 2026-04-06
The standard of care for Devic syndrome, also known as Neuromyelitis Optica Spectrum Disorder (NMOSD), involves a dual-strategy approach of managing acute attacks with corticosteroids and plasmapheresis, followed by long-term immunosuppressive therapy to prevent relapses. Pharmacological Management Modern management of Devic syndrome / NMO has been transformed by FDA-approved therapies specifically designed for patients who are anti-aquaporin-4 (AQP4) antibody-positive. First-line maintenance treatments often include monoclonal antibodies such as eculizumab (Soliris), satralizumab (Enspryng), and inebilizumab (Uplizna).
3 people with Devic Syndrome / NMO have shared their first-person experience on this question at DiseaseMaps.
What are the best treatments for Devic Syndrome / NMO?
Treatments for Devic Syndrome / NMO: what real patients say works for them, alongside a medically reviewed overview citing sources like NIH GARD and Orphanet.
The standard of care for Devic syndrome, also known as Neuromyelitis Optica Spectrum Disorder (NMOSD), involves a dual-strategy approach of managing acute attacks with corticosteroids and plasmapheresis, followed by long-term immunosuppressive therapy to prevent relapses.
Pharmacological Management
Modern management of Devic syndrome / NMO has been transformed by FDA-approved therapies specifically designed for patients who are anti-aquaporin-4 (AQP4) antibody-positive. First-line maintenance treatments often include monoclonal antibodies such as eculizumab (Soliris), satralizumab (Enspryng), and inebilizumab (Uplizna). For patients who do not have access to these targeted biologics, clinicians may utilize off-label immunosuppressants like rituximab (Rituxan), mycophenolate mofetil (CellCept), or azathioprine to manage Devic syndrome / NMO and reduce the frequency of optic neuritis and transverse myelitis episodes.
Non-Pharmacological and Supportive Care
Because Devic syndrome / NMO can result in lasting neurological deficits, comprehensive care must include physical therapy to maintain mobility, occupational therapy to assist with daily living tasks, and pain management specialists to address chronic neuropathic pain. Mental health support is also vital, as the unpredictable nature of relapses often impacts the emotional well-being of those living with the condition.
Multidisciplinary Care and Personalization
Treatment effectiveness for Devic syndrome / NMO varies significantly based on the patient’s antibody status and the severity of their initial presentation. A robust care team should include a neurologist specializing in neuroimmunology, an ophthalmologist, a urologist, and a physiatrist. Because every case of Devic syndrome / NMO is unique, all therapeutic decisions must be personalized by your medical team to balance efficacy with your individual health profile.
Medical Disclaimer: This information is for educational purposes and does not constitute medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions regarding a medical condition.
References
- NIH Genetic and Rare Diseases Information Center (GARD): Neuromyelitis optica
- Orphanet: Neuromyelitis optica
- The Sumaira Foundation for NMO
Posted Sep 27, 2017 by Erica Pretty 600
Posted Jun 8, 2018 by Tash 3050
Posted Jul 6, 2018 by Ravi 1500
